Skip to main content
. 2003 Dec;134(3):378–384. doi: 10.1046/j.1365-2249.2003.02286.x

Table 3.

T cell activation using RNA-transfected dendritic cells

Study Type of RNA Transfection Activation
Nair et al. [18] CEA RNA PP/LIPO CD8+/CD4+
Thornburg et al. [29] HPV E6, E7 RNA LIPO CD8+
Heiser et al. [30] PSA RNA PP CD8+
Weissman et al.[31] HIV gag RNA LIPO CD8+/CD4+
Su et al. [28] TERT RNA LIPO CD8+/CD4+
Strobel et al. [19] IMP RNA LIPO CD8+
Ponsaerts et al. [21] IMP RNA EP CD8+
Ponsaerts et al. [32] IMP RNA EP CD8+
Saebφe-Larssen et al. [22] TERT RNA EP CD8+
Kalady et al. [23] Melan-A RNA EP CD8+
Heiser et al.[33] Total renal tumour RNA PP CD8+
Heiser et al. [35] Prostate tumour RNA (Ampl.) PP CD8+
Milazzo et al. [36] Total myeloma RNA EP CD8+

Type of RNA: CEA, carcino-embryonic antigen; HPV, human papillomavirus; PSA, prostate specific antigen; HIV, human immunodeficiency virus; TERT, telomerase; IMP, influenza matrix protein; Melan-A, melanoma antigen; Ampl., amplified. Transfection: PP, passive pulsing; LIPO, lipofection, EP, electroporation.